Discuss Xeomin and current public payer formulary access criteria and new indications in an effort to secure coverage that reflects the current Health Canada approved indications. To discuss potential new indications and future products to assist the BC drug Formulary in preparing for future potential coverage needs.
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health, Hospitals
|